Mobile-health Network Solutions addresses recent share price fluctuations, reaffirms long-term commitment

SINGAPORE, May 06, 2024 — Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today addresses recent market fluctuations in its share price with a message from Co-Founders Dr Siaw Tung Yeng and Dr Rachel Teoh Pui Pui. Dear Valued Shareholders, Investors, Employees, and Partners, we are writing today to […]

Osaka University Hospital Department of Nuclear Medicine Receives Funding for Training From ICPO Foundation

Prof. Dr. Tadashi Watabe, a medical doctor at Osaka University Hospital and associate professor at Osaka University, is an active member of the ICPO Foundation. On May 6, 2024 – in Wiesbaden, Germany, and Osaka, Japan, the International Centers for Precision Oncology (ICPO) Foundation announced a cooperation with the Department of Nuclear Medicine at the […]

UrbanLink Orders 20 Lilium Jets with Option for 20 More from U.S. Operator

UrbanLink’s firm purchase order of 20 Lilium Jets, with an option for 20 more, includes scheduled pre-delivery payments.The agreement marks a critical aviation milestone as UrbanLink becomes the first airline in the U.S. fully committed to integrating eVTOL aircraft into its fleet.UrbanLink will begin operations with a regional network connecting cities in South Florida. MIAMI, […]

Boehringer Ingelheim shares promising results from first worldwide study on diabetic macular ischemia

Boehringer Ingelheim today presented encouraging data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic macular ischemia (DMI). The study found that BI 764524 was well tolerated following intravitreal administration of single and multiple doses, meeting its primary safety endpoints and showed […]

Web3 GP to Showcase Daytona Supercar Sim Racing at Three Hong Kong Blockchain Conferences in May

Join Web3 GP at three Hong Kong blockchain conferences this May, where sim racetracks become the battleground for an unprecedented display of speed, technology, and automotive artistry. HONG KONG, May 06, 2024 — , a ground-breaking supercar racing platform that integrates Web3 Play-to-Earn (P2E) technology with open-source technology from the hottest racing sims, has announced […]

Jayud Global Logistics Receives Notice from Nasdaq Regarding Failure to Meet Continued Listing Requirements

SHENZHEN, China, May 03, 2024 — Jayud Global Logistics Limited (NASDAQ: JYD) (“Jayud” or the “Company”), a leading end-to-end supply chain solution provider based in Shenzhen, specializing in cross-border logistics, today announced that on May 1, 2024, it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it no longer […]

Genius Group Partners with MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program

Singapore, May 03, 2024 — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading provider of AI-powered, digital-first education solutions, has engaged international investor relations specialists MZ Group (“MZ”) to lead a strategic investor relations and financial communications program across all key markets. MZ Group will work closely with Genius Group’s […]

Genius Group to Present at Sidoti Micro Cap Conference

Singapore, May 03, 2024 — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading provider of AI-powered, digital-first education solutions, will be participating in the Sidoti Micro Cap Conference virtually Wednesday, May 8 and Thursday, May 9, 2024. The Company is scheduled to present on Wednesday, May 8th, at 10:00 a.m. […]

Haoxi Health Technology Limited Enters into Advertising Placement Service Framework Agreement

BEIJING, May 03, 2024 — Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that Beijing Haoxi Digital Technology Co., Ltd. (“Haoxi Beijing”), a wholly-owned subsidiary of the Company, entered into a Framework Contract for Cooperation on Information Placement on Media Platforms (the “Framework Contract”) […]

BTCC Announces World Trading Competition with Record $10 Million USD Prize Pool

VILNIUS, Lithuania, May 03, 2024 — BTCC, the world’s longest-running cryptocurrency platform, is announcing the launch of the BTCC World Trading Competition (BWTC) 2024, featuring an unprecedented prize pool of 10 million USDT. This global competition, organized into three main categories, invites participants worldwide, underscoring BTCC’s commitment to inclusivity and diversity in cryptocurrency trading. The […]

WadzPay Plans to Expand into Stablecoin Business Line

SINGAPORE, May 03, 2024 — WadzPay, a leading fintech company specializing in blockchain-based technology for virtual asset payment solutions, is proud to announce its plan to enter the Stablecoin business, marking a significant expansion of its offerings. With a steadfast commitment to innovation and addressing evolving market demands, the company has strategically positioned itself to […]

SIMPPLE LTD. Receives Nasdaq Notification Regarding Share Price Issue

Singapore, May 02, 2024 — SIMPPLE LTD. (Nasdaq: SPPL) (the “Company” or “SIMPPLE”), an advanced technology solution provider in the emerging property-technology (“PropTech”) space, today announced that it has received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) dated April 26, 2024, notifying the Company that based on the closing bid price of […]

Primeline notified of guarantee enforcement

Not for distribution to the U.S. news wire services, or dissemination in the United States. HONG KONG, May 02, 2024 — Primeline Energy Holdings Inc. (“Primeline” or the “Company”) announces that it has received notice of enforcement of its guarantee of the indebtedness of its subsidiaries, Primeline Energy China Limited (“PECL”) and Primeline Petroleum Corporation […]

ASLAN Pharmaceuticals to Study Differences Between Eblasakimab and Other Biologics Through Expanded Collaboration With Zenyaku

New research collaboration will explore the differentiation of eblasakimab’s mechanism of action versus biologic therapies for atopic dermatitis (AD), dupilumab and lebrikizumab. The findings will deepen understanding of the biology underlying the recent finding that some AD patients may respond to eblasakimab even after having an inadequate response to dupilumab. The first part of the […]